Clinical Role - Hospital
Pharmacy Times® is at the forefront of providing the latest clinical updates, patient counseling tools and innovative solutions to hospital pharmacists and reaches more than 200,000 pharmacy professionals in total.
Although cancer deaths with the highest death rates per capita accounted for the greatest number of years lost, the study authors said cancers that typically occur in younger populations had a disproportionate share of the burden.
In an interview with Pharmacy Times, Peter Bonis, MD, chief medical officer of clinical effectiveness at Wolters Kluwer Health, said formulary adherence in health systems is essential for several reasons.
In an interview with Pharmacy Times, Peter Bonis, MD, chief medical officer of clinical effectiveness at Wolters Kluwer Health, said collaboration between pharmacists, physicians, and other health care workers is essential.
Strategies and types of tests used by clinicians to help exclude various conditions that may present similarly to immune thrombocytopenia during a diagnostic work-up.
Early diagnosis, surgery while cancer is confined to kidney are key, but pharmacological agents are used for Stage IV.
In the midst of a pandemic, visibility and interoperability have never been more critical when it comes to medication inventory.
It can be administered as a fixed-dose formulation over approximately 3 to 5 minutes, which is significantly less time than the intravenous (IV) formulation.
The companies expect to product up to 50 million doses globally before the end of 2020, and up to 1.3 billion doses by the end of 2021.
Yet those directly involved in caring for the underserved and uninsured see its value firsthand.
Although the announcement comes when many patients are trying to avoid unnecessary trips to stores or physicians’ offices, the offerings of Amazon will have a massive impact on traditional retail pharmacies.
With more awareness of the susceptibility to coinfection with varicella zoster virus and pneumocystic jirovecii, clinicians should aggressively seek signs of opportunistic infections in susceptible patients and treat them accordingly.
The newest indication is the first approval of pembrolizumab for breast cancer, according to Merck.